APOE and Alzheimer disease: Furthermore, longitudinal studies revealed that the APOE ε4 genotype is predictive of an increased decline in general cognition in MCI, as the ε4 carriers had a significantly more rapid decline [45] in addition to a higher conversion rate to AD, as mentioned above [23,24].